Literature DB >> 8603905

Epizootiologic evaluation of urolithiasis in cats: 3,498 cases (1982-1992).

R Thumchai1, J Lulich, C A Osborne, V L King, E M Lund, W E Marsh, L K Ulrich, L A Koehler, K A Bird.   

Abstract

OBJECTIVE: to test the hypothesis that breed, sex and age of cats, and anatomic location of uroliths are risk factors for calcium oxalate and magnesium ammonium phosphate urolithiasis.
DESIGN: Retrospective case-control study. SAMPLE POPULATION: Records of 3,498 feline urolith accessions submitted between September 1982 and September 1992. PROCEDURE: Mineral composition of feline uroliths was quantitatively analyzed. Odds ratios and 95% confidence intervals were calculated for breed, sex, age, and urolith location as risk factors for calcium oxalate and magnesium ammonium phosphate urolith formation. The population at risk was defined as all cats for which that type of urolith had been submitted. The control population was all cats for which uroliths had been submitted, excluding cats with the type of urolith being evaluated.
RESULTS: Burmese, Persian, and Himalayan breeds were at higher risk for developing calcium oxalate uroliths, but at reduced risk for developing magnesium ammonium phosphate uroliths. Compared with females, neutered male cats had a higher risk for developing calcium oxalate uroliths, but a reduced risk for developing magnesium ammonium phosphate uroliths. The risk for calcium oxalate urolith formation increased with age. One- to 2-year-old female cats had the highest risk for magnesium ammonium phosphate uroliths. Uroliths removed from the kidneys were more likely to be composed of calcium oxalate than of magnesium ammonium phosphate. CLINICAL IMPLICATIONS: Breed, sex, and age of cats, and anatomic location of uroliths should be considered when evaluating risk of calcium oxalate and magnesium ammonium phosphate urolithiasis in urolith-forming cats.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603905

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  8 in total

1.  Feline urethral plugs and bladder uroliths: a review of 5484 submissions 1998-2003.

Authors:  Doreen M Houston; Andrew E P Moore; Michael G Favrin; Brent Hoff
Journal:  Can Vet J       Date:  2003-12       Impact factor: 1.008

Review 2.  Pathogenesis of calcium oxalate urinary stone disease: species comparison of humans, dogs, and cats.

Authors:  Allison L O'Kell; David C Grant; Saeed R Khan
Journal:  Urolithiasis       Date:  2017-03-30       Impact factor: 3.436

3.  Canine and feline urolithiasis: examination of over 50 000 urolith submissions to the Canadian veterinary urolith centre from 1998 to 2008.

Authors:  Doreen M Houston; Andrew E P Moore
Journal:  Can Vet J       Date:  2009-12       Impact factor: 1.008

4.  Evaluation of 21 426 feline bladder urolith submissions to the Canadian Veterinary Urolith Centre (1998-2014).

Authors:  Doreen M Houston; Nick P Vanstone; Andrew E P Moore; Heather E Weese; J Scott Weese
Journal:  Can Vet J       Date:  2016-02       Impact factor: 1.008

5.  The silicon concentration in cat urine and its relationship with other elements.

Authors:  Fumihito Takahashi; Mariko Mochizuki; Takuya Yogo; Katsumi Ishioka; Norio Yumoto; Toshinori Sako; Fukiko Ueda; Masahiro Tagawa; Hiroyuki Tazaki
Journal:  J Vet Med Sci       Date:  2013-12-11       Impact factor: 1.267

6.  An experimental model for calcium carbonate urolithiasis in goats.

Authors:  Meredyth L Jones; Brandon J Dominguez; Michael A Deveau
Journal:  J Vet Intern Med       Date:  2018-03-10       Impact factor: 3.333

7.  Epidemiology of feline urolithiasis in Mexico (2006-2017).

Authors:  Claudia I Mendoza-López; Javier Del-Angel-Caraza; María A Aké-Chiñas; Israel A Quijano-Hernández; Marco A Barbosa-Mireles
Journal:  JFMS Open Rep       Date:  2019-11-24

Review 8.  Animal models of naturally occurring stone disease.

Authors:  Ashley Alford; Eva Furrow; Michael Borofsky; Jody Lulich
Journal:  Nat Rev Urol       Date:  2020-11-06       Impact factor: 16.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.